Myasthenia Gravis

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/28

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:00 AM on 10/6/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

29 Terms

1
New cards

What is myasthenia gravis?

- An autoimmune disease characterised by weakness of skeletal muscle.

- Caused by a decrease in transmission of autoantibodies through the neuromuscular junction causing muscular weakness

2
New cards

Describe the pathophysiology of myasthenia gravis.

- Autoantibodies against the muscle nicotinic acetylcholine receptors are made.

- They bind to these receptors preventing acetycholine binding to them.

- This causes inhibition of the transmission at the NMJ causing muscular weakness.

<p>- Autoantibodies against the muscle nicotinic acetylcholine receptors are made.</p><p>- They bind to these receptors preventing acetycholine binding to them.</p><p>- This causes inhibition of the transmission at the NMJ causing muscular weakness.</p>
3
New cards

How is acetylcholine produced?

Acetylcholine is made from acetyl-CoA and choline.

The enzyme choline acetyltransferase (ChAT) combines them.

It's stored in vesicles until nerve signals trigger its release.

4
New cards

What are choline esterases and what are the two types of choline esterases?

- Enzymes which break down acetylcholine.

- Types include: acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE)

5
New cards

Describe AChE.

- Can be membrane bound in the synaptic cleft or soluble in the presynaptic terminal.

- Only found at ACh synapses and sweat glands (SymNS)

- Specific for ACh.

6
New cards

Describe BuChE.

- Widespread distribution in body e.g., plasma, liver skin.

- Less specific to substrates.

7
New cards

Describe the events in a normal healthy NMJ.

- Action potential reaches axon terminal which causes voltage gated Ca2+ channels to open.

- This causes an influx of Ca2+ which depolarises the axon terminal.

- This leads to exocytosis of vesicles containing acetylcholine

- Acetylcholine then diffuses across the synaptic cleft interacting with Nicotinic acetylcholine receptors.

8
New cards

Which muscles are most likely to be affected by myasthenia gravis?

- Muscles which are most in use e.g., Eyes and face

- Use-dependent producing symptoms such as drooping eyelids and lack of facial expression.

9
New cards

What are the causes of myasthenia gravis?

- Age (peaks between 60-80 in men and 20-3- in women)

- Loss of nAChRs at the NMJ

10
New cards

What are the symptoms of myasthenia gravis?

- Ocular symptoms e.g., drooping eyelids, double vision.

- Lack of facial expressions

- Slurred speech

- Difficulties chewing and swallowing.

- Fatigue and shortness in breath which can lead to myasthenic crisis which is severe.

11
New cards

What are tests for myasthenia gravis?

- Ice test

- Blood tests for autoantibodies

- Neurophysiology

- Edrophonium test

12
New cards

Describe the Ice Test for myasthenia gravis.

Placing ice on the muscle helps improve symptoms as it cools the muscle.

13
New cards

What are treatments for myasthenia gravis?

- Acetylcholinesterase inhibitors e.g., pyridostigmine

- Immunosuppressive therapy e.g., azathiopurine

- IV immunoglobulin

- Thymectomy

14
New cards

Why are acetylcholinesterase inhibitors good treatments for myasthenia gravis?

- MG causes a decresae in binding between acetylcholine and receptors.

- Prevents the breakdown of acetylcholine in the synaptic cleft.

- This allows acetylcholine to present for much longer in the synaptic cleft so it can keep exciting neurons (increase in twitch tension).

- This increases the binding between acetylcholine and receptors treating the disease.

15
New cards

What are the 3 main groups of cholinesterase inhibitors?

- Short acting e.g., Edrophonium

- Medium e.g., neostigmine and pyridostigmine

- Irreversible e.g., malathion and novichok.

16
New cards

What are general effects of cholinesterase inhibitors?

- Bradycardia, vasodilation, decreased BP

- Contraction of smooth muscle in bladder and bronchioles.

- Pupil constriction, constriction of ciliary muscles.

- Secretion of enzymes.

- Sweat increase

17
New cards

How is myasthenia gravis managed?

- Avoid disease triggers

- Symptomatic treatment

- Immunosuppressant drugs

- Immunomodulatory treatments

18
New cards

What are triggers for myasthenia gravis?

- Infection

- Stress/trauma

- Thyroid dysfunction

- Anaemia

- Electrolyte imbalances

- Medicines

19
New cards

How are oral acetylcholinesterase inhibitors prescribed?

- 15mg QDS with food.

- Can increase to 60mg QDS

20
New cards

What are side effects of acetylcholinesterase inhibitors?

- Muscle and abdominal cramps (nicotinic effects)

- Cramps, diarrhoea, increased sweating (muscarinic)

21
New cards

Why do acetylcholinesterase inhibitors produce these side-effects?

- They activate the parasympathetic nervous system which stimulates contraction.

- This causes smooth and skeletal muscle to contract causing convulsions, difficulty breathing, increased gut motility and pupil constriction.

22
New cards

How can side-effects be managed?

- Making sure patients are taking drugs with food.

- Co-prescribing with oral-anticholinergic drugs e.g., glycopyrrolate.

- Providing loperamide for diarrhoea.

23
New cards

Why are acetylcholinesterase inhibitors cautioned with asthma, bradycardia, hypotension, peptic ulceration?

- Stimulates constriction of airways and therefore exacerbates asthma.

- Stimulates muscarinic receptors in the heart which control SA and AV nodes which slow down heart rate exacerbating bradycardia and hypotension.

- Stimulates gastric acid secretion which can worsen peptic ulcers.

24
New cards

What structural features allows acetylcholine to bind to acetylcholine esterase?

- Trimethyl on nitrogen fits into he hydrophobic pocket of enzyme.

- Ester oxygen forms an H-bond with the tyrosine residue on enzyme.

- Ionic interaction between Positive nitrogen and aspartic acid.

These hold acetylcholine in place for hydrolysis to occur (catalytic triad).

- Close to the catalytic triad which catalyses hydrolysis of acetylcholine.

<p>- Trimethyl on nitrogen fits into he hydrophobic pocket of enzyme.</p><p>- Ester oxygen forms an H-bond with the tyrosine residue on enzyme.</p><p>- Ionic interaction between Positive nitrogen and aspartic acid.</p><p>These hold acetylcholine in place for hydrolysis to occur (catalytic triad).</p><p> </p><p>- Close to the catalytic triad which catalyses hydrolysis of acetylcholine.</p>
25
New cards

How does the catalytic triad catalyse hydrolysis of acetylcholine?

Activates serine for nucleophilic attack

26
New cards

Show the hydrolysis of acetylcholine.

- This leaves acetylcholine esterase inactive as the serine residue is still acylated.

- Requires regeneration to reuse enzyme.

<p>- This leaves acetylcholine esterase inactive as the serine residue is still acylated.</p><p>- Requires regeneration to reuse enzyme.</p>
27
New cards

How is acetylcholine esterase regenerated?

knowt flashcard image
28
New cards

What structural features are required to develop a reversible acetylcholine esterase inhibitor?

- Suitable leaving group e.g., phenol

- Group that is less susceptible to hydrolysis than acetyl which allows slower regeneration.

- Positively charged nitrogen atom which allows orientation of molecule in active site.

<p>- Suitable leaving group e.g., phenol</p><p>- Group that is less susceptible to hydrolysis than acetyl which allows slower regeneration.</p><p>- Positively charged nitrogen atom which allows orientation of molecule in active site.</p>
29
New cards

Describe irreversible acetylcholine esterase inhibitors.

- Contain reactive groups, such as phosphorus, capable of forming strong covalent bonds with the serine residue which cannot be hydrolysed.

- This leads to prolonged activation of cholinergic receptors.